Clinical Efficacy of Apple Polyphenol for Treating Cedar Pollinosis | Zendy

Kazumasa Kishi | Zendy; Masahiro Saito | Zendy; Takao Saito | Zendy; Megumi Kumemura | Zendy; Hiroshi OKAMATSU | Zendy; Misa Okita | Zendy; Kenji Takazawa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Efficacy of Apple Polyphenol for Treating Cedar Pollinosis

Author(s) -

Kazumasa Kishi,

Masahiro Saito,

Takao Saito,

Megumi Kumemura,

Hiroshi OKAMATSU,

Misa Okita,

Kenji Takazawa

Publication year - 2005

Publication title -

bioscience biotechnology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.509

H-Index - 116

eISSN - 1347-6947

pISSN - 0916-8451

DOI - 10.1271/bbb.69.829

Subject(s) - medicine , placebo , adverse effect , polyphenol , pollen , clinical efficacy , traditional medicine , dermatology , botany , biology , pathology , biochemistry , alternative medicine , antioxidant

A double-blind comparative study was conducted on cedar pollinosis patients in order to evaluate the treatment efficacy of apple polyphenol (Ap). Ap was administered (500 mg) once daily for 12 weeks, starting about 2 weeks prior to cedar pollen dispersion. Pollinosis symptoms during the study were evaluated according to the classification in the guidelines for allergic rhinitis diagnosis and treatment. The results show that the sneezing score was significantly lower for the Ap group than with the placebo group during the early period of pollen dispersion and during the main dispersion period. In addition, no adverse reactions were induced by Ap during the study. These results suggest that Ap may alleviate the symptoms of cedar pollinosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research